González-Moles Miguel Ángel, Ramos-García Pablo, Esteban Francisco
School of Dentistry, University of Granada, 18010 Granada, Spain.
Instituto de Investigación Biosanitaria ibs.GRANADA, 18012 Granada, Spain.
Cancers (Basel). 2021 Mar 17;13(6):1349. doi: 10.3390/cancers13061349.
The objective of our study has been, through a systematic review and meta-analysis, to increase the scientific evidence on the implications of SP and its receptor NK-1R in head and neck carcinogenesis. We searched studies published before May-2020 without date and publication language restrictions (PubMed, Embase, Web of Science, Scopus). We evaluated the quality of the studies included (QUIPS tool). We performed heterogeneity, sensitivity, small-study effects, and subgroup analyses. A total 16 studies and 1308 cases met inclusion criteria. Qualitative evaluation demonstrated that not all studies were performed with the same scientific rigor, finding the greatest risk of bias in the study confounding and prognostic factors measurement domains. Quantitative evaluation showed a greater SP/NK-1R overexpression in malignant head and neck lesions compared to benign lesions ( = 0.02), and that expression was observed in malignant salivary gland pathology. Likewise, we found a higher overexpression of NK-1R compared to SP ( = 0.02). In conclusion, the results of this systematic review and meta-analysis show evidence that the upregulation of SP and NK-1R are oncogenic events involved in head and neck carcinogenesis, probably acting in the early stages of malignization. In addition, there is evidence of a greater relevance of the upregulation of the NK-1R receptor compared to SP, which highlights the interest in deepening the development of targeted therapies on the receptor. Future studies assessing the relationships between SP/NK-1R among subjects with head and neck tumors could consider the recommendations given in this systematic review and meta-analysis to improve and standardize future research.
我们这项研究的目的是,通过系统评价和荟萃分析,增加关于速激肽(SP)及其受体神经激肽-1受体(NK-1R)在头颈部癌发生中的影响的科学证据。我们检索了2020年5月之前发表的研究,无日期和出版语言限制(PubMed、Embase、Web of Science、Scopus)。我们评估了纳入研究的质量(QUIPS工具)。我们进行了异质性、敏感性、小研究效应和亚组分析。共有16项研究和1308例病例符合纳入标准。定性评估表明,并非所有研究都以相同的科学严谨性进行,发现在研究混杂和预后因素测量领域存在最大的偏倚风险。定量评估显示,与良性病变相比,恶性头颈部病变中SP/NK-1R的过表达更高( = 0.02),并且在恶性唾液腺病理学中观察到了这种表达。同样,我们发现NK-1R的过表达高于SP( = 0.02)。总之,这项系统评价和荟萃分析的结果表明,有证据显示SP和NK-1R的上调是参与头颈部癌发生的致癌事件,可能在恶性化的早期阶段起作用。此外,有证据表明NK-1R受体上调比SP具有更大的相关性,这凸显了深入开展针对该受体的靶向治疗的研究意义。未来评估头颈部肿瘤患者中SP/NK-1R之间关系的研究可以考虑本系统评价和荟萃分析中给出的建议,以改进和规范未来的研究。